NPI: 1326107319 · GEORGETOWN, KY 40324 · Rural Acute Care Hospital · NPI assigned 12/06/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 12/06/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 105,733 | $6.31M |
| 2019 | 97,456 | $5.25M |
| 2020 | 103,487 | $4.94M |
| 2021 | 123,893 | $6.04M |
| 2022 | 129,449 | $6.54M |
| 2023 | 134,616 | $7.84M |
| 2024 | 102,197 | $7.11M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 27,359 | 21,993 | $6.70M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 30,806 | 26,037 | $4.73M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6,935 | 5,558 | $4.38M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,958 | 5,641 | $2.59M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7,011 | 6,313 | $2.30M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,317 | 2,661 | $1.90M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15,164 | 13,698 | $1.46M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 13,403 | 10,055 | $1.25M |
| 70450 | Computed tomography, head or brain; without contrast material | 5,488 | 4,075 | $1.07M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3,471 | 2,685 | $935K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 15,745 | 12,747 | $934K |
| G0378 | Hospital observation service, per hour | 2,458 | 1,709 | $934K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,195 | 3,998 | $679K |
| 71045 | Radiologic examination, chest; single view | 13,439 | 9,117 | $665K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,587 | 9,538 | $660K |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,373 | 7,594 | $643K |
| 80053 | Comprehensive metabolic panel | 59,392 | 34,524 | $547K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,250 | 1,038 | $543K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 11,706 | 3,103 | $516K |
| 71046 | Radiologic examination, chest; 2 views | 7,516 | 6,379 | $478K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 10,868 | 3,764 | $459K |
| 96361 | Intravenous infusion, hydration; each additional hour | 17,881 | 7,978 | $433K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,570 | 1,193 | $387K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,523 | 6,471 | $333K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 343 | 284 | $300K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,625 | 1,455 | $250K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 39,215 | 30,386 | $243K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4,055 | 3,645 | $236K |
| 87486 | 9,886 | 6,493 | $206K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,338 | 2,058 | $186K |
| 87581 | 6,977 | 6,315 | $186K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 7,067 | 6,321 | $184K |
| 72125 | Computed tomography, cervical spine; without contrast material | 819 | 706 | $183K |
| 73562 | 2,574 | 1,941 | $182K | |
| 72100 | 1,929 | 1,541 | $181K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,309 | 4,362 | $168K |
| 73630 | 2,277 | 1,981 | $161K | |
| 74018 | 2,767 | 2,406 | $157K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,335 | 2,257 | $151K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 10,910 | 6,489 | $149K |
| 72131 | 574 | 445 | $144K | |
| 73610 | 2,075 | 1,738 | $144K | |
| 36415 | Collection of venous blood by venipuncture | 34,867 | 16,757 | $141K |
| J2704 | Injection, propofol, 10 mg | 9,256 | 8,084 | $135K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 295 | 261 | $133K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6,513 | 2,138 | $133K |
| 73130 | 1,933 | 1,653 | $124K | |
| 73030 | 1,943 | 1,416 | $118K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14,763 | 12,145 | $118K |
| J7030 | Infusion, normal saline solution , 1000 cc | 13,584 | 7,508 | $116K |
| 84484 | 9,780 | 7,476 | $108K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 231 | 213 | $102K |
| 96376 | 2,745 | 1,445 | $102K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,846 | 2,313 | $99K |
| 93971 | 613 | 530 | $99K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,708 | 1,190 | $98K |
| 71250 | 460 | 332 | $90K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,975 | 3,424 | $88K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,789 | 1,428 | $83K |
| 81025 | 8,060 | 6,959 | $77K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,380 | 7,029 | $75K |
| 41899 | Unlisted procedure, dentoalveolar structures | 115 | 88 | $73K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,621 | 4,104 | $72K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 267 | 216 | $70K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 185 | 93 | $70K |
| 73110 | 1,129 | 916 | $68K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,755 | 1,513 | $68K |
| 83690 | 12,584 | 10,256 | $68K | |
| 81001 | 21,577 | 17,761 | $67K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,677 | 4,334 | $61K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,858 | 4,515 | $59K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,024 | 878 | $59K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,875 | 2,440 | $55K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,615 | 8,863 | $54K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,983 | 5,041 | $47K |
| 86677 | 1,340 | 1,078 | $46K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,426 | 2,211 | $44K |
| 85027 | 7,006 | 6,029 | $43K | |
| 83970 | 1,258 | 1,100 | $43K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 187 | 150 | $43K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,810 | 5,618 | $41K |
| 87070 | 5,518 | 4,857 | $40K | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 1,214 | 694 | $39K |
| 82728 | 3,323 | 2,914 | $38K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,861 | 3,741 | $36K |
| 93017 | 213 | 188 | $35K | |
| 83735 | 6,956 | 5,293 | $35K | |
| 82962 | 6,484 | 3,518 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,616 | 2,941 | $34K |
| 97535 | Self-care/home management training, each 15 minutes | 1,864 | 1,425 | $34K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,776 | 2,466 | $33K |
| 90715 | 1,024 | 800 | $33K | |
| 80061 | Lipid panel | 3,059 | 2,564 | $31K |
| 82746 | 2,648 | 2,405 | $31K | |
| 97162 | 1,072 | 874 | $31K | |
| 70486 | 133 | 121 | $31K | |
| 83921 | 1,859 | 1,681 | $31K | |
| 83880 | 1,323 | 1,032 | $31K | |
| 87522 | Neg quan hep c or qual rna | 727 | 680 | $31K |
| 84425 | 1,696 | 1,525 | $30K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4,373 | 3,518 | $30K |
| 76830 | Ultrasound, transvaginal | 173 | 160 | $29K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,160 | 1,708 | $29K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 10,020 | 8,465 | $29K |
| 83605 | 3,340 | 2,649 | $28K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,036 | 1,622 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,807 | 3,374 | $26K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 26 | 25 | $26K |
| 87507 | 106 | 88 | $25K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,547 | 1,289 | $25K |
| 72040 | 327 | 236 | $25K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 723 | 300 | $24K |
| 85610 | 7,575 | 4,904 | $24K | |
| 84703 | 3,670 | 3,220 | $23K | |
| 70498 | 57 | 55 | $22K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 765 | 673 | $22K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 745 | 671 | $21K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 408 | 375 | $21K |
| 87040 | 1,713 | 1,279 | $20K | |
| 84145 | 1,130 | 923 | $20K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,344 | 2,054 | $19K |
| 87186 | 2,780 | 2,339 | $19K | |
| 87077 | 3,470 | 2,485 | $19K | |
| 83540 | 3,240 | 2,916 | $17K | |
| 85379 | 2,233 | 1,959 | $17K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 888 | 781 | $17K |
| 20610 | 85 | 41 | $16K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,453 | 2,881 | $16K |
| 84446 | 1,401 | 1,259 | $16K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,579 | 1,304 | $16K |
| 84134 | 1,274 | 1,099 | $16K | |
| 97533 | 780 | 326 | $15K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 848 | 746 | $14K |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,598 | 1,082 | $14K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 873 | 774 | $14K |
| 73080 | 208 | 164 | $14K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 251 | 228 | $13K |
| 73502 | 244 | 183 | $13K | |
| 82607 | 1,125 | 956 | $13K | |
| 84590 | 1,415 | 1,272 | $13K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,676 | 1,720 | $13K |
| 29125 | 181 | 168 | $12K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 66 | 55 | $12K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,944 | 1,566 | $12K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 555 | 517 | $12K |
| C9113 | Injection, pantoprazole sodium, per vial | 953 | 564 | $12K |
| 85730 | 2,903 | 2,418 | $12K | |
| 84702 | 961 | 796 | $11K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 815 | 642 | $11K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 33 | 27 | $11K |
| 76642 | 120 | 108 | $11K | |
| 83550 | 1,545 | 1,424 | $11K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 809 | 647 | $10K |
| 86140 | 2,527 | 1,926 | $10K | |
| 70496 | 30 | 29 | $10K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 642 | 386 | $10K |
| 12001 | 111 | 102 | $10K | |
| 84439 | 1,049 | 954 | $9K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 51 | 39 | $9K |
| 94760 | 237 | 192 | $8K | |
| C1726 | Catheter, balloon dilatation, non-vascular | 89 | 52 | $8K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 61 | 51 | $8K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 12 | 12 | $7K |
| J2785 | Injection, regadenoson, 0.1 mg | 60 | 50 | $7K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 147 | 137 | $7K |
| 84100 | 1,932 | 1,446 | $7K | |
| 73590 | 123 | 90 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 133 | 119 | $7K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,063 | 886 | $7K |
| 97161 | 183 | 175 | $6K | |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | 520 | 435 | $6K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 13 | 12 | $6K |
| 62323 | 18 | 14 | $5K | |
| 86850 | 759 | 553 | $5K | |
| 72141 | 14 | 13 | $5K | |
| 73090 | 82 | 67 | $5K | |
| 87902 | 15 | 15 | $5K | |
| 85652 | 2,034 | 1,653 | $4K | |
| 80074 | 132 | 108 | $4K | |
| 87420 | 383 | 359 | $4K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 69 | 37 | $4K |
| 86706 | 380 | 366 | $4K | |
| J1815 | Injection, insulin, per 5 units | 112 | 64 | $4K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 228 | 174 | $4K |
| 86900 | 1,470 | 1,191 | $4K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 196 | 180 | $4K |
| 86901 | 1,456 | 1,191 | $4K | |
| J1171 | Injection, hydromorphone, 0.1 mg | 54 | 44 | $3K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 379 | 333 | $3K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 274 | 200 | $3K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 14 | 13 | $3K |
| 73140 | 43 | 41 | $3K | |
| 82550 | 586 | 444 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 600 | 478 | $3K |
| 87340 | 282 | 272 | $3K | |
| J3490 | Unclassified drugs | 1,009 | 824 | $3K |
| 74240 | 15 | 12 | $3K | |
| 86704 | 253 | 226 | $3K | |
| 36416 | 186 | 123 | $3K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 144 | 131 | $2K |
| 87900 | 15 | 15 | $2K | |
| 86705 | 209 | 199 | $2K | |
| 82565 | 132 | 92 | $2K | |
| 82248 | 396 | 281 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 16 | 16 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | 253 | 114 | $2K |
| 64488 | 16 | 12 | $2K | |
| 10060 | 27 | 24 | $2K | |
| C9399 | Unclassified drugs or biologicals | 55 | 43 | $2K |
| 86708 | 139 | 131 | $2K | |
| 76536 | 12 | 12 | $2K | |
| 82172 | 89 | 83 | $2K | |
| 94060 | 16 | 13 | $1K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 39 | 36 | $1K |
| 20553 | 24 | 12 | $1K | |
| 92609 | 71 | 28 | $1K | |
| 71271 | 66 | 60 | $1K | |
| 94729 | 36 | 31 | $1K | |
| 83010 | 91 | 85 | $1K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 67 | 54 | $1K |
| 71101 | 17 | 13 | $1K | |
| 82784 | 144 | 128 | $1K | |
| 82977 | 137 | 125 | $1K | |
| 83615 | 196 | 159 | $1K | |
| 74019 | 12 | 12 | $999.88 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 71 | 63 | $935.02 |
| 87220 | 198 | 169 | $922.26 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 56 | 48 | $872.20 |
| 94726 | 30 | 26 | $821.08 | |
| 87210 | 185 | 161 | $807.87 | |
| J3480 | Injection, potassium chloride, per 2 meq | 50 | 37 | $806.29 |
| J3370 | Injection, vancomycin hcl, 500 mg | 18 | 12 | $747.87 |
| J1790 | Injection, droperidol, up to 5 mg | 69 | 59 | $738.63 |
| 97165 | 30 | 25 | $716.53 | |
| 97116 | 36 | 24 | $681.91 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 63 | 44 | $662.44 |
| 82247 | 140 | 91 | $654.89 | |
| 92523 | 12 | 12 | $600.49 | |
| 84460 | 119 | 106 | $590.30 | |
| 80069 | 50 | 40 | $549.65 | |
| J1956 | Injection, levofloxacin, 250 mg | 47 | 37 | $516.37 |
| 82785 | 31 | 25 | $493.76 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 45 | 12 | $474.99 |
| 84550 | 68 | 52 | $426.24 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 199 | 179 | $378.17 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 13 | 12 | $355.16 |
| 82570 | 40 | 25 | $317.36 | |
| 84153 | 27 | 25 | $262.85 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 38 | 28 | $252.10 |
| 84436 | 48 | 41 | $247.17 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 19 | 12 | $238.39 |
| 83516 | 14 | 13 | $219.74 | |
| 82104 | 12 | 12 | $207.64 | |
| 82103 | 12 | 12 | $202.10 | |
| J1644 | Injection, heparin sodium, per 1000 units | 35 | 13 | $167.04 |
| 86038 | 14 | 14 | $165.72 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 14 | 12 | $153.73 |
| 80076 | 16 | 15 | $132.70 | |
| 99406 | 16 | 12 | $130.11 | |
| 82553 | 12 | 12 | $128.02 | |
| J7510 | Prednisolone oral, per 5 mg | 152 | 142 | $112.93 |
| 84479 | 17 | 12 | $59.14 | |
| 84156 | 19 | 13 | $50.15 | |
| 82009 | 13 | 12 | $45.01 | |
| 85014 | 18 | 12 | $23.34 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 15 | 13 | $17.74 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 65 | 58 | $0.00 |